Nurix enrolls first patient in bexobrutideg combination trial

Markets Investing.com By Investing.com 07 Oct 2026 05:04 1 min read
Nurix enrolls first patient in bexobrutideg combination trial Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.